Literature DB >> 11240029

Expression of functional mu-opioid receptors during T cell development.

L McCarthy1, I Szabo, J F Nitsche, J E Pintar, T J Rogers.   

Abstract

We have examined the chemotactic responsiveness of thymocytes to selective mu-, kappa-, and delta-opioid agonists. Our results show that developing T cells migrate in response to mu-, but not kappa- or delta-opioids. The mu-opioid response appears to be dependent on the classical mu-opioid receptor (MOR-1) since the chemotactic response is blocked by a selective mu-opioid antagonist, and is absent in thymocytes from MOR-1-deficient mice. Flow cytometric analysis of the mu-opioid responsive cells shows that these cells consist predominantly of highly immature CD4- CD8- T cells. These results represent the first demonstration of the functional expression of mu-opioid receptors by developing T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11240029     DOI: 10.1016/s0165-5728(01)00248-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  15 in total

Review 1.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

Review 2.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

3.  micro-Opioid receptor activation prevents acute hepatic inflammation and cell death.

Authors:  Dania Chakass; David Philippe; Edmone Erdual; Sébastien Dharancy; Mathilde Malapel; Caroline Dubuquoy; Xavier Thuru; Jerome Gay; Claire Gaveriaux-Ruff; Pierre Dubus; Philippe Mathurin; Brigitte L Kieffer; Pierre Desreumaux; Mathias Chamaillard
Journal:  Gut       Date:  2007-02-13       Impact factor: 23.059

4.  Effect of chronic morphine administration on circulating T cell population dynamics in rhesus macaques.

Authors:  William D Cornwell; Mark G Lewis; Xiaoxuan Fan; Jay Rappaport; Thomas J Rogers
Journal:  J Neuroimmunol       Date:  2013-09-20       Impact factor: 3.478

5.  Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation.

Authors:  David Philippe; Laurent Dubuquoy; Hervé Groux; Valérie Brun; Myriam Tran Van Chuoï-Mariot; Claire Gaveriaux-Ruff; Jean-Frédéric Colombel; Brigitte L Kieffer; Pierre Desreumaux
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 6.  Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression.

Authors:  M J Finley; C M Happel; D E Kaminsky; T J Rogers
Journal:  Cell Immunol       Date:  2008-02-14       Impact factor: 4.868

7.  Regulation of mu opioid receptor expression in developing T cells.

Authors:  Lily Zhang; Judith Sliker Belkowski; Tammi Briscoe; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-25       Impact factor: 4.147

8.  Expression of the mu opioid receptor in the human immunodeficiency virus type 1 transgenic rat model.

Authors:  Sulie L Chang; Jose A Beltran; Shilpa Swarup
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

9.  Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts.

Authors:  David A Nielsen; Vadim Yuferov; Sara Hamon; Colin Jackson; Ann Ho; Jurg Ott; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-07-23       Impact factor: 7.853

10.  Opioids and clonidine modulate cytokine production and opioid receptor expression in neonatal immune cells.

Authors:  R Chavez-Valdez; L Kovell; R Ahlawat; G L McLemore; M Wills-Karp; E B Gauda
Journal:  J Perinatol       Date:  2012-10-04       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.